Understand diet and erectile-function evidence, the limits of libido claims, and FDA warnings about some sexual-enhancement products.
Laboratory analysis reported by the FDA found undeclared sildenafil and acetaminophen in 10 Day Forecast, a product promoted for sexual enhancement.
The agency described the findings in an October 2026 safety notice.
It warned that sildenafil could interact with nitrates and lower blood pressure to dangerous levels.
The nutrition claim at issue is that a particular food or supplement can reliably increase libido or alter hormones on demand. It presents eating or taking a product as a direct way to produce a sexual response.
That claim deserves a precise reading. A reader may be asking about sexual interest while a headline is describing erections. Getting those terms clear is the starting point for evaluating the promise.
NIDDK guidance, as summarized in a review of diet and erectile dysfunction, says a healthy diet can lower the risk of erectile dysfunction and improve its symptoms. Erectile dysfunction is often shortened to ED.
The guidance focuses on an overall eating pattern. It includes these food groups:
Mediterranean-style eating is discussed as one relevant approach. This gives the discussion a concrete basis: an identifiable way of eating and a defined sexual-function outcome.
The review describes a cohort of 21,469 men who initially had no ED, heart attack, diabetes or stroke. Among men under 60, those with the highest Mediterranean-diet scores had a 22% lower risk of developing ED than those with the lowest scores.
That comparison looked at the development of ED over time. The starting point matters: these men did not have ED when they entered the cohort. Researchers were examining dietary-pattern scores alongside the later development of a specific sexual-function problem.
The same review describes a two-year Italian study. In the Mediterranean-diet group, 13 men reached a normal erectile-function score. Two men in the control group reached that score.
Here the outcome was a change in measured erectile function. This is a different question from whether men without ED later developed it. Keeping the outcome visible makes it easier to understand what each study adds to the discussion.
The FDA's sexual-enhancement product guidance warns that many products marketed for sexual enhancement may contain dangerous hidden ingredients. It also says these products are not guaranteed to work.
The laboratory finding in the opening illustrates that ingredient-safety concern. A product promoted for sexual enhancement needs scrutiny of what it contains, not just an assessment of the health message on its label. Ordinary dietary guidance and a marketed product therefore raise different questions.
This distinction matters when evaluating a nutrition claim. Evidence supporting an eating pattern does not serve as evidence for a separate sexual-enhancement product. Each needs to be judged on the evidence relevant to it.
The dietary evidence summarized here concerns erectile function, mainly in men. It does not establish benefits for desire, arousal, intimacy or hormone levels in every person. Nor does it establish that a particular meal will improve everyday energy.
This is especially important for women reading a general headline about libido. These ED findings do not provide evidence of a corresponding effect on women's desire. A broader headline needs broader evidence rather than an assumption that all sexual outcomes move together.
For readers sorting out the language, distinguishing libido from attraction helps keep the question focused on the experience they mean.
The cohort followed eating habits rather than assigning a diet. Its observed difference is an association, not proof that the diet prevented ED. The association was weaker in older age groups.
The intervention findings concern men with ED and metabolic risk. They are study-specific results rather than a forecast for an individual. Together, these details explain why the evidence deserves attention without turning it into a uniform expectation.
The useful distinction is between a result observed in a defined group and a prediction about one person's experience. Those are not the same statement. A study can contribute meaningful evidence without providing an individual promise.
The studies described do not establish that any one food reliably produces an immediate sexual effect. A finding about a whole pattern cannot identify which item caused a benefit or turn an ingredient into a reliable libido tool.
That leaves room for a person to value a way of eating while noticing no clear change in desire. It also leaves room for sexual experiences to change without proving that a recent food choice was responsible. A personal observation can be worth discussing without being treated as proof of a food's effect.
The FDA's warnings are not proof that every supplement contains hidden drugs. The product-specific notice documents what testing found in that product. It is a safety finding with a defined scope, not a verdict on all foods or all supplements.
One grounded approach is to match the promised change with the outcome the evidence measured. This is an evidence-reading tool, not a diet plan or a way to diagnose a sexual concern.
For that last point, the FDA advises consulting a health professional before trying a new product. It also says that a product's absence from its notification list does not establish that it is safe.
This approach is useful even when the answer is simply that a claim does not match the available evidence. It allows a reader to keep food-pattern guidance in its proper place without dismissing nutrition or turning a meal into a measure of sexual success.
It also changes the standard used to judge a headline. The question becomes whether the evidence supports the stated outcome in the people studied. That is more informative than asking whether an ingredient has acquired a reputation for supporting sexual wellbeing.
For someone whose concern is changing desire rather than erections, the next conversation can begin with that distinction. Naming reduced interest directly is more precise than borrowing language about physical performance that does not describe the concern. There is no need to turn that description into a diagnosis before raising it.
Personal questions about changing sexual function can be taken to a qualified health professional. Sexential's guide to framing decisions about sexual changes with age offers related educational context without selecting a treatment.
Sexual wellbeing deserves attention without a performance test at every meal.
Treating evidence about erections as a promise of greater desire is the kind of confusion Sexential aims to prevent through clear sexual wellbeing education. Its coverage places changing libido and arousal within biological and everyday circumstances for adults aged 35 to 65, supporting informed questions rather than personal treatment choices.
Follow Sexential for thoughtful guidance on desire, sexual function, hormones, confidence, relationships and intimacy. Explore new articles and evidence-aware resources for sexual wellbeing across adulthood.
Learn how medicines may affect sexual function, what to note before a medication review and why prescription changes belong in a clinician discussion.
A study reports more severe menopause symptoms among autistic women. Its self-reported findings raise questions about understanding and support.
An eight-week shatavari study reported sexual-function gains versus placebo. Read the findings, study limits and comparison with a different extract.
Explore practical resources on desire, function, hormones, confidence, intimacy and sexual wellbeing.
Read the Blog
